Jiangsu Hengrui Medicine Co Ltd (600276) — Capital Reinvestment Ratio
Jiangsu Hengrui Medicine Co Ltd (600276) has a Capital Reinvestment Ratio of 0.09x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥4.81 Billion) in capital expenditures (CN¥446.90 Million). See 600276 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu Hengrui Medicine Co Ltd Capital Reinvestment Ratio (1999–2024)
This chart tracks Jiangsu Hengrui Medicine Co Ltd's Capital Reinvestment Ratio across 26 annual periods. Check 600276 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Jiangsu Hengrui Medicine Co Ltd (1999–2024)
Year-by-year Capital Reinvestment Ratio for Jiangsu Hengrui Medicine Co Ltd from 1999 to 2024. For live market cap and broader valuation context, see 600276 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.27x | CN¥7.42 Billion | CN¥1.97 Billion | ▲ +36.7% |
| 2023 | 0.19x | CN¥7.64 Billion | CN¥1.48 Billion | ▼ -87.7% |
| 2022 | 1.57x | CN¥1.27 Billion | CN¥1.99 Billion | ▲ +299.0% |
| 2021 | 0.39x | CN¥4.22 Billion | CN¥1.66 Billion | ▲ +144.3% |
| 2020 | 0.16x | CN¥3.43 Billion | CN¥554.33 Million | ▲ +9.8% |
| 2019 | 0.15x | CN¥3.82 Billion | CN¥561.35 Million | ▼ -22.9% |
| 2018 | 0.19x | CN¥2.77 Billion | CN¥529.11 Million | ▲ +27.8% |
| 2017 | 0.15x | CN¥2.55 Billion | CN¥380.30 Million | ▼ -65.2% |
| 2016 | 0.43x | CN¥2.59 Billion | CN¥1.11 Billion | ▲ +147.6% |
| 2015 | 0.17x | CN¥2.28 Billion | CN¥394.09 Million | ▼ -8.7% |
| 2014 | 0.19x | CN¥1.57 Billion | CN¥298.52 Million | ▼ -42.9% |
| 2013 | 0.33x | CN¥1.36 Billion | CN¥453.30 Million | ▼ -31.8% |
| 2012 | 0.49x | CN¥958.37 Million | CN¥466.83 Million | ▼ -52.5% |
| 2011 | 1.02x | CN¥527.36 Million | CN¥540.27 Million | ▲ +37.9% |
| 2010 | 0.74x | CN¥385.95 Million | CN¥286.73 Million | ▲ +130.3% |
| 2009 | 0.32x | CN¥439.12 Million | CN¥141.65 Million | ▼ -65.9% |
| 2008 | 0.95x | CN¥117.46 Million | CN¥111.21 Million | ▲ +210.0% |
| 2007 | 0.31x | CN¥218.87 Million | CN¥66.85 Million | ▼ -5.8% |
| 2006 | 0.32x | CN¥266.18 Million | CN¥86.29 Million | ▲ +17.1% |
| 2005 | 0.28x | CN¥227.88 Million | CN¥63.07 Million | ▼ -26.7% |
| 2004 | 0.38x | CN¥209.41 Million | CN¥79.11 Million | ▼ -76.1% |
| 2003 | 1.58x | CN¥136.82 Million | CN¥216.62 Million | ▼ -35.8% |
| 2002 | 2.47x | CN¥49.84 Million | CN¥122.90 Million | ▼ -89.7% |
| 2001 | 23.99x | CN¥11.49 Million | CN¥275.58 Million | ▲ +478.2% |
| 2000 | 4.15x | CN¥19.61 Million | CN¥81.34 Million | ▲ +591.8% |
| 1999 | 0.60x | CN¥33.89 Million | CN¥20.32 Million | — |